Vivien Wong
Direktor/Vorstandsmitglied bei CYCLO THERAPEUTICS, INC.
Vermögen: 11 375 $ am 30.04.2024
Profil
Vivien Wong is currently an Independent Director at Cyclo Therapeutics, Inc. since 2023 and a Director at Burke Neurological Institute since 2022.
Previously, Dr. Wong worked as the Vice President-Product Development at Progenics Pharmaceuticals, Inc. from 2007 to 2021 and as a Principal at Theritas Pharmaceutical Consultants from 2004 to 2007.
Dr. Wong completed an undergraduate degree at Mississippi University for Women and a doctorate degree at the University of Maryland School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CYCLO THERAPEUTICS INC
0,03% | 01.03.2024 | 8 818 ( 0,03% ) | 11 375 $ | 30.04.2024 |
Aktive Positionen von Vivien Wong
| Unternehmen | Position | Beginn |
|---|---|---|
| CYCLO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 17.08.2023 |
| Burke Neurological Institute | Direktor/Vorstandsmitglied | 01.01.2022 |
Ehemalige bekannte Positionen von Vivien Wong
| Unternehmen | Position | Ende |
|---|---|---|
| Theritas Pharmaceutical Consultants | Corporate Officer/Principal | 01.09.2007 |
| PROGENICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2021 |
Ausbildung von Vivien Wong
| Mississippi University for Women | Undergraduate Degree |
| University of Maryland School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CYCLO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
| Theritas Pharmaceutical Consultants | |
| Burke Neurological Institute |
